Collegium Pharmaceutical (COLL)
Commercializes ADHD and pain-management medicines across a U.S. prescription portfolio.
$22.66
vs last close−0.12 (−0.53%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 43 days
EPS estimate
$1.80
Revenue estimate
$218.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$1.77$1.49$1.68$2.25$2.04$1.76$1.92Pending
Estimate$1.54$1.43$1.62$1.86$2.14$1.52$1.72$1.80
Surprise+14.9%+4.2%+3.7%+21.0%−4.7%+15.8%+11.6%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$181.9M$177.8M$188.0M$209.4M$205.4M$193.5M$199.9MPending
Estimate$179.7M$173.1M$191.3M$206.2M$206.4M$184.5M$199.6M$218.0M
Surprise+1.3%+2.7%−1.7%+1.6%−0.4%+4.9%+0.1%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $1.88 | — | — |
| Sep 2027 | $1.77 | — | — |
| Jun 2027 | $1.65 | — | — |
| Mar 2027 | $1.54 | — | — |
| Dec 2026 | $1.92 | — | — |
| Nov 2026 | $1.80 | — | — |
| Aug 2026 | $1.72 | $1.92 | +11.6% |
| May 2026 | $1.52 | $1.76 | +15.8% |
| Feb 2026 | $2.14 | $2.04 | −4.7% |
| Nov 2025 | $1.86 | $2.25 | +21.0% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $1.88 | — | — | $239.0M | — | — | — |
| Sep 2027 | $1.77 | — | — | $234.0M | — | — | — |
| Jun 2027 | $1.65 | — | — | $223.0M | — | — | — |
| Mar 2027 | $1.54 | — | — | $190.2M | — | — | — |
| Dec 2026 | $1.92 | — | — | $224.6M | — | — | — |
| Nov 5, 2026 | $1.80 | — | — | $218.0M | — | — | — |
| Aug 6, 2026 | $1.72 | $1.92 | +11.6% | $199.6M | $199.9M | +0.1% | −18.6% |
| May 7, 2026 | $1.52 | $1.76 | +15.8% | $184.5M | $193.5M | +4.9% | +7.7% |
| Feb 26, 2026 | $2.14 | $2.04 | −4.7% | $206.4M | $205.4M | −0.4% | −3.3% |
| Nov 6, 2025 | $1.86 | $2.25 | +21.0% | $206.2M | $209.4M | +1.6% | +13.4% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Feb 22, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 10, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 27, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 8, 2019 | |||||||
| Feb 27, 2019 | |||||||
| Nov 8, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 9, 2018 | |||||||
| Mar 7, 2018 | |||||||
| Nov 8, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 9, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Aug 10, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 15, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Aug 12, 2015 |